Get started
CureVac N.V.CureVac N.V.CureVac N.V.

CureVac N.V.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsETFs

CVAC/N chart


Full chart

CVAC/N upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪22.38 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
6.06
Basic EPS (TTM)
18.60 MXN
Net income (FY)
‪3.66 B‬ MXN
Revenue (FY)
‪12.07 B‬ MXN
Shares float
‪95.50 M‬
Beta (1Y)
1.18

Employees


Employees (FY)
983
Change (1Y)
−189 −16.13%
Revenue / Employee (1Y)
‪12.28 M‬ MXN
Net income / Employee (1Y)
‪3.72 M‬ MXN

About CureVac N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Alexander Zehnder
Website
curevac.com
Headquarters
Tübingen
Founded
2020
ISIN
NL0015436031
FIGI
BBG00YM3WXY9
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.

Check out other big names from the same industry as CVAC/N.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CVAC/N news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs with CVAC/N exposure


IBB
iShares Biotechnology ETF
Weight
0.05%
Market value
‪3.05 M‬
USD
MNA
NYLI Merger Arbitrage ETF
Weight
0.57%
Market value
‪1.39 M‬
USD
XXSC
Xtrackers MSCI Europe Small Cap UCITS ETF Capitalisation 1C
Weight
0.04%
Market value
‪1.15 M‬
USD
MMS
Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF DIST
Weight
0.19%
Market value
‪840.58 K‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.11%
Market value
‪692.31 K‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.11%
Market value
‪692.31 K‬
USD
UEFD
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR dis- Distribution
Weight
0.09%
Market value
‪678.27 K‬
USD
EMUSCD.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR Ukdis- Distribution
Weight
0.09%
Market value
‪678.27 K‬
USD
EMUSC.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR acc- Capitalisation
Weight
0.09%
Market value
‪678.27 K‬
USD
ARB
AltShares Merger Arbitrage ETF
Weight
0.65%
Market value
‪577.47 K‬
USD
ONEQ
Fidelity Nasdaq Composite Index ETF
Weight
0.01%
Market value
‪483.06 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of CVAC/N is 100.00 MXN — it has decreased by −0.70% in the past 24 hours. Watch CureVac N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange CureVac N.V. stocks are traded under the ticker CVAC/N.
We've gathered analysts' opinions on CureVac N.V. future price: according to them, CVAC/N price has a max estimate of 102.29 MXN and a min estimate of 100.00 MXN. Watch CVAC/N chart and read a more detailed CureVac N.V. stock forecast: see what analysts think of CureVac N.V. and suggest that you do with its stocks.
CVAC/N stock is 1.52% volatile and has beta coefficient of 1.18. Track CureVac N.V. stock price on the chart and check out the list of the most volatile stocks — is CureVac N.V. there?
Today CureVac N.V. has the market capitalization of ‪22.63 B‬, it has decreased by −1.65% over the last week.
Yes, you can track CureVac N.V. financials in yearly and quarterly reports right on TradingView.
CureVac N.V. is going to release the next earnings report on Nov 18, 2025. Keep track of upcoming events with our Earnings Calendar.
CVAC/N earnings for the last quarter are −3.31 MXN per share, whereas the estimation was −4.02 MXN resulting in a 17.50% surprise. The estimated earnings for the next quarter are −3.23 MXN per share. See more details about CureVac N.V. earnings.
CureVac N.V. revenue for the last quarter amounts to ‪282.84 M‬ MXN, despite the estimated figure of ‪73.76 M‬ MXN. In the next quarter, revenue is expected to reach ‪275.34 M‬ MXN.
CVAC/N net income for the last quarter is ‪−1.12 B‬ MXN, while the quarter before that showed ‪−728.60 M‬ MXN of net income which accounts for −54.14% change. Track more CureVac N.V. financial stats to get the full picture.
No, CVAC/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 4, 2025, the company has 983 employees. See our rating of the largest employees — is CureVac N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CureVac N.V. EBITDA is ‪5.66 B‬ MXN, and current EBITDA margin is 42.00%. See more stats in CureVac N.V. financial statements.
Like other stocks, CVAC/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CureVac N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CureVac N.V. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CureVac N.V. stock shows the neutral signal. See more of CureVac N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.